PCIG
TECH icon

Partners Capital Investment Group’s Bio-Techne TECH Stock Holding History

Partners Capital Investment Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,746
Closed -$289K – 252
2023
Q4 		$289K Buy
+3,746
New +$247K 0.01% 228
2023
Q3 		– Sell
-3,314
Closed -$271K – 261
2023
Q2 		$271K Buy
+3,314
New +$266K 0.01% 192

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Partners Capital Investment Group's TECH Position: Q1 2024 in Review

Partners Capital Investment Group sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 3,746 shares — an estimated $289K sold.

Partners Capital Investment Group first reported a position in TECH in Q2 2023 and held it in 2 quarters. The position peaked at $289K in Q4 2023. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

  • Partners Capital Investment Group reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
  • Partners Capital Investment Group sold 3,746 Bio-Techne shares in Q1 2024, an estimated $289K.
  • Partners Capital Investment Group first reported a position in Bio-Techne in Q2 2023 and held it in 2 quarters.
  • Partners Capital Investment Group's Bio-Techne position peaked at $289K in Q4 2023.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Partners Capital Investment Group's 13F filing for Q1 2024, filed 14 May 2024.